Yes good. When the early or interim data in patients does actually arrive in this PNOC combo study -(it will likely be presented by Australia's Dr Matt Dun) ......be great if the FDA does consent to early marketing approval of paxalisib and the other drug.
This is what all stakeholders hope for. There is no treatment and it seems very apparent the drug combo works very well. If anybody can get things moving fast, it is the White House.
Maybe watch the YouTube presentation and look for FDA accelerated approval discussion (over and above normal FDA processes)
__________________________________________________________
CHIMERIX news release just now
"We are excited to participate in the Cancer Moonshot Brain Cancers Forum on this topic today, which is critically important to the patients we serve. We hope our participation will help identify new actions that can accelerate progress, resulting in better outcomes for patients with brain cancer.”
The purpose of the Cancer Moonshot Brain Cancers Forum is to align on the greatest challenges that, if addressed, would lead to better outcomes for GBM and DIPG patients, identify ways to accelerate ongoing efforts and generate commitments to spur action, imbue hope, and serve as models for other rare cancers.
KZA Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
